CAV1 and myeloid sarcoma: A loss of Cav‐1 expression has been associated with neurodegeneration, suggesting that the purinergic complex upstream of the Cav‐1 gene may serve as a binding site for inflammatory transcription factors, representing a novel susceptibility locus in MS pathophysiology [118, 119].